CIK 0001660334
- Non-accelerated filer
- Smaller reporting company
Verrica Pharmaceuticals Inc.
Sign in to watch- Ticker
- VRCA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 463137900
- Phone
- +1 484-453-3300
- Business address
- 44 WEST GAY STREET, SUITE 400, WEST CHESTER, PA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-17 | Zawitz David Chief Operating Officer | Purchase | +6,000 | $4.98 | $30K | 27,000 |
| 2026-06-05 | Zawitz David Chief Operating Officer | Grant or award · Employee Stock Option (right to buy) | +171,340 | 171,340 | ||
| 2025-11-25 | Zawitz David Chief Operating Officer | Purchase | +10,000 | $4.24 | $42K | 21,000 |
| 2025-11-25 | Zawitz David Chief Operating Officer | Purchase · Series C Warrant (right to buy) | +2,500 | 2,500 | ||
| 2024-12-09 | Zawitz David Chief Operating Officer | Grant or award · Employee Stock Option (right to buy) | +950,000 | 950,000 |
Page 1 of 1 · 5 trades